A detailed history of Affinity Asset Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 325,000 shares of ARWR stock, worth $6.42 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
325,000
Previous 50,000 550.0%
Holding current value
$6.42 Million
Previous $1.3 Million 384.37%
% of portfolio
1.09%
Previous 0.18%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$19.36 - $29.54 $5.32 Million - $8.12 Million
275,000 Added 550.0%
325,000 $6.29 Million
Q2 2024

Aug 14, 2024

SELL
$21.87 - $28.24 $1.53 Million - $1.98 Million
-70,000 Reduced 58.33%
50,000 $1.3 Million
Q1 2024

May 14, 2024

BUY
$27.21 - $39.48 $3.27 Million - $4.74 Million
120,000 New
120,000 $3.43 Million

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.09B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.